BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2019

Oct 30, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2019-10-25

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-25	Common Stock	M	5000	$21.51	Acquired	332520	Direct
2019-10-25	Common Stock	S	5000	$69.550	Disposed	327520	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-25	Stock Option (Right to buy Common Stock)	$21.51	M	5000	Disposed	2020-05-11	Common Stock (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	181341	Indirect

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on September 6, 2019.

F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.